- Home
- EPAC vs CPRX Comparison
EPAC vs CPRX Comparison
Compare EPAC & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EPAC
- CPRX
- Stock Information
- Founded
- EPAC 1910
- CPRX 2002
- Country
- EPAC United States
- CPRX United States
- Employees
- EPAC N/A
- CPRX N/A
- Industry
- EPAC Industrial Machinery/Components
- CPRX Biotechnology: Pharmaceutical Preparations
- Sector
- EPAC Technology
- CPRX Health Care
- Exchange
- EPAC Nasdaq
- CPRX Nasdaq
- Market Cap
- EPAC 2.3B
- CPRX 2.6B
- IPO Year
- EPAC N/A
- CPRX 2006
- Fundamental
- Price
- EPAC $42.24
- CPRX $20.02
- Analyst Decision
- EPAC Strong Buy
- CPRX Strong Buy
- Analyst Count
- EPAC 2
- CPRX 5
- Target Price
- EPAC $50.50
- CPRX $33.20
- AVG Volume (30 Days)
- EPAC 324.3K
- CPRX 1.5M
- Earning Date
- EPAC 10-15-2025
- CPRX 11-05-2025
- Dividend Yield
- EPAC 0.09%
- CPRX N/A
- EPS Growth
- EPAC 7.49
- CPRX 183.96
- EPS
- EPAC 1.63
- CPRX 1.65
- Revenue
- EPAC $608,099,000.00
- CPRX $558,499,000.00
- Revenue This Year
- EPAC $6.25
- CPRX $16.51
- Revenue Next Year
- EPAC $5.39
- CPRX $9.58
- P/E Ratio
- EPAC $26.07
- CPRX $12.10
- Revenue Growth
- EPAC 2.82
- CPRX 28.55
- 52 Week Low
- EPAC $36.51
- CPRX $19.15
- 52 Week High
- EPAC $51.91
- CPRX $26.58
- Technical
- Relative Strength Index (RSI)
- EPAC 52.12
- CPRX 46.35
- Support Level
- EPAC $41.61
- CPRX $19.66
- Resistance Level
- EPAC $43.37
- CPRX $20.52
- Average True Range (ATR)
- EPAC 1.02
- CPRX 0.67
- MACD
- EPAC -0.13
- CPRX 0.03
- Stochastic Oscillator
- EPAC 50.00
- CPRX 42.08
About EPAC Enerpac Tool Group Corp.
Enerpac Tool Group Corp provides high-precision tools, controlled-force products, and solutions for precise heavy lifting. The company has one reportable segment, the Industrial Tools & Services (IT&S) Segment. The IT&S segment is engaged in the design, manufacture, and distribution of branded hydraulic and mechanical tools and in providing services and tool rental to the refinery/petrochemical; general industrial; industrial maintenance, repair, and operations (MRO); machining & manufacturing; power generation; infrastructure; mining; and other markets. Geographically, the company has operations in Algeria, Australia, Brazil, France, Germany, Kazakhstan, India, Italy, Japan, Norway, Poland, Saudi Arabia, Singapore, South Africa, South Korea, Spain, and the United Arab Emirates.
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).